Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 3 Interventional

The CSF Shunt Entry Site Trial

ClinicalTrials.gov ID: NCT02425761

Public ClinicalTrials.gov record NCT02425761. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 9:06 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Controlled Trial of Anterior Versus Posterior Entry Site for Cerebrospinal Fluid Shunt Insertion

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to compare the survival time (time to first shunt failure) of ventriculoperitoneal (VP) shunts inserted through an anterior entry site with those inserted through a posterior entry site in children. Shunt entry site is the location on the head that the shunt catheter enters the brain on its path to the fluid-filled spaces in the brain, the ventricles. Entry sites can be anterior or posterior.

Study identification

NCT ID
NCT02425761
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Baylor College of Medicine
Other
Enrollment
448 participants

Conditions and interventions

Conditions

Interventions

Procedure

Eligibility (public fields only)

Age range
1 Day to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 1, 2015 (Actual)
Primary completion
Dec 31, 2020 (Estimated)
Completion
Dec 31, 2020 (Estimated)
Last update posted
Nov 12, 2020

2015 – 2020

United States locations

U.S. sites
11
U.S. states
11
U.S. cities
11
Facility City State ZIP Site status
Children's Hospital of Alabama Birmingham Alabama 35233 —
Children's Hospital of Los Angeles Los Angeles California 90027 —
Children's Hospital Colorado Denver Colorado 80045 —
Johns Hopkins Children's Center Baltimore Maryland 21287 —
St. Louis Children's Hospital St Louis Missouri 63110 —
Nationwide Children's Hospital Columbus Ohio 43205 —
Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15224 —
Monroe Carell Jr Children's Hospital at Vanderbilt Nashville Tennessee 37232 —
Texas Children's Hospital Houston Texas 77030 —
Primary Children's Medical Center Salt Lake City Utah 84113 —
Seattle Children's Hospital Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02425761, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 12, 2020 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02425761 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →